Forge Biologics, Author at Forge Biologics - Page 13 of 13

Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit

Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

Forge Biologics Strengthens Leadership with Key Hires

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Strengthens Leadership with Key Hires

Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies 

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies